Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Progenitor Cells”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03288844
What this trial is testing

Follow-up Study After ACLSCT for Restoration of Corneal Epithelium in Patients With LSCD Due to Ocular Burns

Who this might be right for
Limbal Stem Cell Deficiency Due to Ocular Burn
Holostem s.r.l. 47
Not applicableStudy completedNCT02463344
What this trial is testing

Long Term Follow Up of Sub-retinal Transplantation of hESC Derived RPE Cells in Patients With AMD

Who this might be right for
Age-Related Macular Degeneration
Astellas Institute for Regenerative Medicine 11
Not applicableStudy completedNCT00445744
What this trial is testing

Cyclophosphamide and Busulfan Followed by Donor Stem Cell Transplant in Treating Patients With Myelofibrosis, Acute Myeloid Leukemia, or Myelodysplastic Syndrome

Who this might be right for
Adult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)+19 more
Fred Hutchinson Cancer Center 52
Not applicableLooking for participantsNCT03000244
What this trial is testing

Long-Term Follow up of Patients Undergoing Hematopoietic Stem Cell Transplantation, Cellular Therapy, or Gene Therapy

Who this might be right for
Cellular Immunotherapy, AdoptiveGenetic TherapyTissue Donors+1 more
National Cancer Institute (NCI) 2,000
Not applicableLooking for participantsNCT06812598
What this trial is testing

Efficacy of Extended Letermovir Prophylaxis to Prevent CMV Reactivation in High-Risk Chinese Adults Undergoing Allogeneic HSCT

Who this might be right for
Cytomegalovirus InfectionsCMV
The First Affiliated Hospital of Soochow University 330
Testing effectiveness (Phase 2)Active Not RecruitingNCT04314687
What this trial is testing

Stem Cell and Conditioned Medium for Cerebral Palsy

Who this might be right for
Cerebral Palsy
PT. Prodia Stem Cell Indonesia 78
Not applicableUnknownNCT03759899
What this trial is testing

HAECs Are Preliminarily Applied in Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Leukemia
Peking University People's Hospital 30
Very early researchEnded earlyNCT00394316
What this trial is testing

Gene Therapy for Chronic Granulomatous Disease

Who this might be right for
Chronic Granulomatous Disease
National Institute of Allergy and Infectious Diseases (NIAID) 3
Not applicableEnded earlyNCT01739504
What this trial is testing

Autologous Adipose-Derived Stromal Cells Delivered Intra-articularly in Patients With Osteoarthritis.

Who this might be right for
Osteoarthritis
Ageless Regenerative Institute 10
Testing effectiveness (Phase 2)UnknownNCT02209311
What this trial is testing

Effectiveness and Safety of Method of Maxilla Alveolar Process Reconstruction Using Synthetic Tricalcium Phosphate and Autologous MMSCs

Who this might be right for
Partially Edentulous MaxillaAlveolar Bone AtrophyAlveolar Bone Loss
Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation 12
Testing effectiveness (Phase 2)Looking for participantsNCT06483906
What this trial is testing

Venetoclax and Azacitidine Combined With Homoharringtonine, Followed by Allo-HSCT for Intermediate and High-risk AML.

Who this might be right for
Acute Myeloid Leukemia
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 56
Testing effectiveness (Phase 2)UnknownNCT03014102
What this trial is testing

Recombinant Human Thrombopoietin for Mobilization of Peripheral Blood Progenitor Cells for Autologous Transplantation

Who this might be right for
ThrombocytopoietinHematopoietic Stem Cell MobilizationHematopoietic Stem Cell Transplantation
Hongnan Mo 50
Early research (Phase 1)Study completedNCT03371329
What this trial is testing

Mesenchymal Stem Cells Therapy in Patients With Recent Intracerebral Hemorrhage

Who this might be right for
Hemorrhagic StrokeIntracerebral Hemorrhage
Mayo Clinic 9
Testing effectiveness (Phase 2)Study completedNCT00004172
What this trial is testing

Chemotherapy, Filgrastim, and Stem Cell Transplantation With Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer

Who this might be right for
Breast Cancer
Northwestern University
Large-scale testing (Phase 3)Active Not RecruitingNCT00114101
What this trial is testing

Lenalidomide in Treating Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant

Who this might be right for
DS Stage I Multiple MyelomaDS Stage II Multiple MyelomaDS Stage III Multiple Myeloma+2 more
National Cancer Institute (NCI) 460
Not applicableNot Yet RecruitingNCT07137130
What this trial is testing

Secretome TGF Beta 3

Who this might be right for
Melasma
Universitas Indonesia 34
Testing effectiveness (Phase 2)Active Not RecruitingNCT04749667
What this trial is testing

Study of Mesenchymal Autologous Stem Cells as Regenerative Treatment for Multiple Sclerosis

Who this might be right for
Multiple SclerosisProgressive Multiple Sclerosis
Haukeland University Hospital 18
Not applicableStudy completedNCT02425800
What this trial is testing

Human Prostate Tissue Model to Maintain and Study Prostate Cancer Stem Cells

Who this might be right for
Benign Prostatic HyperplasiaProstate Carcinoma
Wake Forest University Health Sciences 43
Testing effectiveness (Phase 2)UnknownNCT02061800
What this trial is testing

CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant

Who this might be right for
Chronic Myeloid Leukemia (CML)Acute Myelogenous Leukemia (AML)Myelodysplastic Syndrome (MDS)+3 more
Diane George 14
Testing effectiveness (Phase 2)Ended earlyNCT01861054
What this trial is testing

Pilot Study to Evaluate Safety & Biological Effects of Orally Administered Reparixin in Early Breast Cancer

Who this might be right for
Breast Cancer
Dompé Farmaceutici S.p.A 20
Next Page